Skip to content

EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07096895
Enrollment
40
Registered
2025-07-31
Start date
2020-02-01
Completion date
2027-01-01
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Altered Anatomy, Biliary Intervention, EDEE, EUS Guided Enteroenteric Anastomosis, Malignant Gastric Outlet Obstruction

Keywords

ERCP, altered anatomy, EUS, anastomosis

Brief summary

Safety and efficacy of EDEE (EUS-directed transenteric ERCP)

Detailed description

Background and Study Objective Endoscopic retrograde cholangiopancreatography (ERCP) is considered the gold standard when biliary intervention is indicated. However, there are situations where conventional ERCP is no longer feasible - for example, in the presence of malignant gastric outlet obstruction. Additionally, the number of patients with surgically altered anatomy due to benign or malignant underlying diseases is increasing. For this group of patients, enteroscopy-assisted ERCP can generally be considered. However, the success rate of this procedure varies depending on the anatomical situation and is only around 61.7%. Therefore, patients in whom the papilla or the biliodigestive anastomosis (BDA) cannot be reached either via conventional endoscopy or enteroscopy-assisted ERCP - yet require biliary intervention - present a particular clinical challenge. Traditionally, the only option in such cases has often been percutaneous transhepatic drainage (PTBD). This approach frequently requires repeated procedures over several months and, in some cases, results in a permanent external drainage. In recent years, endoscopic ultrasound (EUS)-guided techniques have emerged as a promising treatment option for this patient population. These methods show a high technical success rate of approximately 90%, but are not suitable in cases requiring complex interventions (e.g., multiple strictures of the BDA) or when targeting the right biliary system. An alternative approach involves a two-step procedure: first, an EUS-guided entero-enteric anastomosis is created using a lumen-apposing metal stent (LAMS); in a second step, ERCP is performed via the LAMS. This procedure is referred to in the literature as Endoscopic Ultrasound-Directed Transenteric ERCP (EDEE). Since only a few systematic studies on this alternative procedure have been published so far, the objective of this retrospective study is to assess the technical and clinical success rates and evaluate the safety of EDEE.

Interventions

PROCEDUREEDEE (EUS-directed transenteric ERCP)

Technical aspects of EUS-guided anastomosis and ERCP via LAMS (Lumen apposing metal stent)

Sponsors

Evangelisches Krankenhaus Düsseldorf
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* signed consent form * Indication for an EDEE * Age \>18 years

Exclusion criteria

* Age \< 18 years

Design outcomes

Primary

MeasureTime frameDescription
Technical success rateduring the procedurenumber an rate of patients with successful creation of gastro-enterostomy followed by successfull ERCP via LAMS (lumen apposing metal stent) including all planned interventions
Safety of EDEEduring the procedurenumber and rate of patients, in whom a procedure related complication occured

Secondary

MeasureTime frameDescription
Clinical success rateat the day of last procedureabsence of need for alternative drainage
Technical aspects of gastro-enterostomyduring the procedureEvaluation of devices and potential pitfalls creating a gastroenterostomy
Techinical aspect of ERCP via LAMSduring procedureEvaluation of devices and potential pitfalls performing ERCP via LAMS
Requirement for reinterventionsduring the procedure

Countries

Germany

Contacts

Primary ContactCarina Friesl
carina.friesl@evk-duesseldorf.de+49 211 919 2171
Backup ContactLeonie Dr. med. Grossmann
Leonie.Grossmann@evk-duesseldorf.de+49 211 919 1605

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026